Literature DB >> 18440105

Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry.

Tracie L Williams1, Leah Luna, Zhu Guo, Nancy J Cox, James L Pirkle, Ruben O Donis, John R Barr.   

Abstract

Influenza vaccination is the primary method for preventing influenza and its severe complications. Licensed inactivated vaccines for seasonal or pandemic influenza are formulated to contain a preset amount of hemagglutinin (HA), the critical antigen to elicit protection. Current methods to establish the HA concentration of vaccines rely on indirect measurements that are subject to considerable experimental variability. We present a liquid chromatography-tandem mass spectrometry (LC/MS/MS) method for the absolute quantification of viral proteins in a complex mixture. Through use of an isotope dilution approach, HA from viral subtypes H1, H3, H5, and B was determined both directly and rapidly. This method can be applied to purified virus preparations, to monovalent bulk concentrates, or to trivalent inactivated influenza vaccines with improved speed, sensitivity, precision, and accuracy. This LC/MS/MS approach may substantially increase the reliability of methods used to quantitate the amount of antigen in seasonal and pandemic influenza vaccines and reduce the time and effort to deliver influenza vaccines for public health use during the next influenza pandemic.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18440105     DOI: 10.1016/j.vaccine.2008.03.014

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  23 in total

1.  Quantification of viral proteins of the avian H7 subtype of influenza virus: an isotope dilution mass spectrometry method applicable for producing more rapid vaccines in the case of an influenza pandemic.

Authors:  Wanda I Santana; Tracie L Williams; Emily K Winne; James L Pirkle; John R Barr
Journal:  Anal Chem       Date:  2014-04-11       Impact factor: 6.986

2.  Bringing influenza vaccines into the 21st century.

Authors:  Ethan C Settembre; Philip R Dormitzer; Rino Rappuoli
Journal:  Hum Vaccin Immunother       Date:  2013-12-30       Impact factor: 3.452

3.  Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines.

Authors:  Surender Khurana; Christopher Larkin; Swati Verma; Manju B Joshi; Juan Fontana; Alasdair C Steven; Lisa R King; Jody Manischewitz; William McCormick; Rajesh K Gupta; Hana Golding
Journal:  Vaccine       Date:  2011-06-23       Impact factor: 3.641

4.  Development of the H3N2 influenza microneedle vaccine for cross-protection against antigenic variants.

Authors:  Yura Shin; Jeonghun Kim; Jong Hyeon Seok; Heedo Park; Hye-Ran Cha; Si Hwan Ko; Jae Myun Lee; Man-Seong Park; Jung-Hwan Park
Journal:  Sci Rep       Date:  2022-07-16       Impact factor: 4.996

5.  A simple slot blot for the detection of virtually all subtypes of the influenza A viral hemagglutinins using universal antibodies targeting the fusion peptide.

Authors:  Changgui Li; Bozena Jaentschke; Yingli Song; Junzhi Wang; Terry D Cyr; Gary Van Domselaar; Runtao He; Xuguang Li
Journal:  Nat Protoc       Date:  2010-01       Impact factor: 13.491

6.  Limited Tryptic Digestion-Isotope Dilution Mass Spectrometry (LTD-IDMS): A Reagent-Free Analytical Assay To Quantify Hemagglutinin of A(H5N1) Vaccine Material.

Authors:  Hans C Cooper; Yuhong Xie; Giuseppe Palladino; John R Barr; Ethan C Settembre; Yingxia Wen; Tracie L Williams
Journal:  Anal Chem       Date:  2020-08-12       Impact factor: 6.986

7.  Comparative characterization of the glycosylation profiles of an influenza hemagglutinin produced in plant and insect hosts.

Authors:  Sheng Zhang; Robert W Sherwood; Yong Yang; Tara Fish; Wei Chen; James A McCardle; R Mark Jones; Vidadi Yusibov; Eliel Ruiz May; Jocelyn K C Rose; Theodore W Thannhauser
Journal:  Proteomics       Date:  2012-04       Impact factor: 3.984

8.  Identification of Influenza A/PR/8/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs.

Authors:  Adam Johnson; Li-Mei Chen; Emily Winne; Wanda Santana; Maureen G Metcalfe; Guaniri Mateu-Petit; Callie Ridenour; M Jaber Hossain; Julie Villanueva; Sherif R Zaki; Tracie L Williams; Nancy J Cox; John R Barr; Ruben O Donis
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

9.  A novel synthetic receptor-based immunoassay for influenza vaccine quantification.

Authors:  Anwar M Hashem; Caroline Gravel; Aaron Farnsworth; Wei Zou; Michelle Lemieux; Kangwei Xu; Changgui Li; Junzhi Wang; Marie-France Goneau; Maria Merziotis; Runtao He; Michel Gilbert; Xuguang Li
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

Review 10.  Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches.

Authors:  Christine M Thompson; Emma Petiot; Alexandre Lennaertz; Olivier Henry; Amine A Kamen
Journal:  Virol J       Date:  2013-05-04       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.